Conbercept versus Laser for the Treatment of Infants with Zone II Retinopathy of Prematurity

Retinopathy of prematurity (ROP) is a neovascular retinal disorder in preterm infants and a leading cause of childhood blindness in highly industrialized nations.1 Laser photocoagulation, which removes excessive angiogenic stimuli originating from the avascular peripheral retina and prevents retinal detachment effectively, has been the standard treatment for ROP.2 Compared with laser therapy, the use of anti-VEGF agents has advantages such as the convenience of the procedure and continued growth of the physiological retinal vasculature.